NEW YORK (GenomeWeb News) – CombiMatrix today announced that Blue Shield of California has agreed to provide coverage for its diagnostic laboratory services.

The insurer is the third largest in California with more than 3 million members, according to CombiMatrix and combined with the Irvine, Calif.-based firm's existing Multiplan contract, more than 60 million covered lives now have access to CombiMatrix's services, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.